Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

Medicare Drug Plan Subsidies Could Rise Like a Rocket: CBO

X
Your article was successfully shared with the contacts you provided.

If current laws, regulations and programs stay in place roughly as is, federal government subsidies for low-income users of Medicare Part D drug plans might grow rapidly over the next 10 years.

Medicare Part D plan subsidy spending could grow an average of 9% per year from 2019 through 2028, according to analysts at the Congressional Budget Office.

Medicare Part D subsidy spending could increase to $65 billion in 2028, from about $28 billion this year, if the CBO analysts’ projections are correct.

CBO analysts expect overall federal spending on all “mandatory, means-tested” health care program subsidies to grow 5.6% per year over the next decade.

Spending on other types of mandatory, means-tested welfare programs, such as food stamps, could grow an average of just 1.8% per year.

(Related: 18 Federal Health Budget Cut Options)

The CBO analysts included the spending predictions in a new look at federal outlays on mandatory, means-tested programs.

A copy of the analysis is available here.

Definitions

The CBO is an arm of Congress. It helps members of Congress understand the federal budget and federal spending programs, and how policy proposals might affect the federal budget.

CBO analysts define “mandatory” spending as spending required by federal laws.

A “means-tested” program is a program designed to provide help for people with little income, few assets, or both a low income and few assets.

The new analysis excludes spending on programs such as Medicare, which is not means-tested, and on Pell Grant aid for college students, which is discretionary.

The health care section in the new analysis includes spending on Medicaid, Affordable Care Act premium tax credit subsidies, and Children’s Health Insurance Program (CHIP) subsidies as well as Medicare Part D subsidies.

Current Spending

The federal government will spend about $742 billion this year on all kinds of mandatory, means-tested programs.

Food stamps, support for children in foster care, earned income tax credits, and other types of income security programs account for $256 billion of the mandatory, means-tested spending, and health care programs account for $473 billion of the total.

The biggest single mandatory, means-tested program is Medicaid.

The federal government will spend about $383 billion on Medicaid subsidies this year, and, under current law, Medicaid spending could rise 5.5% per year over the next decade, according to CBO projections.

ACA subsidies could grow about 5.2% per year, from $47 billion this year.

CHIP spending could hold steady at about $16 billion.

— Read also, on ThinkAdvisor:

— Connect with ThinkAdvisor Life/Health on Facebook and Twitter.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.